Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive naloxone for postoperative analgesia after total intravenous anesthesia
IRCT20190325043107N85Phase 3Recruiting
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Aug 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of naloxone in postoperative pain (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Postoperative pain intensity, Need for additional analgesics and 1 more. Started Aug 2026; status: recruiting.
02
Drugs
naloxone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20190325043107N85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N85.